This is a routine director sale for compensation-related purposes. The small size relative to market cap and the insider's venture capital affiliation suggest no material concern. Monitor for any acceleration of insider selling ahead of the next earnings report.
GKOS drugs
GKOS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $246.70entry
- T+1 · 12d ago −10.83%α −6.42% · $219.98
- T+5 · 6d ago +0.19%α +1.10% · $247.16
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Gilbert H. Kliman filed a Form 144 notice of intent to sell 2,500 shares of Glaukos Corp common stock, with an estimated aggregate market value of $632,500. The shares were acquired via a stock option exercise on the same day and are being sold for compensation-related purposes. The sale represents a small fraction of the company's $14.1B market cap and is routine for a director.
Key Facts
- Director Gilbert H. Kliman filed Form 144 on 2026-11-04 for 2,500 shares of common stock.
- Estimated aggregate market value of the proposed sale is $632,500.
- Shares were acquired via stock option exercise on the same date (11/04/2026).
- The sale is marked as compensation-related.
- Kliman's address is c/o InterWest Partners, indicating he is a venture capital representative on the board.
- The 2,500 shares represent approximately 0.004% of Glaukos' $14.1B market cap.
- Recent insider activity (30 days) shows 4 sells totaling $10.6M, suggesting this is part of a broader pattern of insider sales.
Financial Impact
$632,500 proposed sale, ~0.004% of market cap
Risk Factors
- Form 144 is only an intent to sell; the actual sale may not occur.
- The filing does not disclose the total holdings of the insider, so the proportional significance cannot be fully assessed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007740 |
| Document: 0001959173-26-007740-index.html | 0001959173-26-007740 |
| Document: 0001959173-26-007740.txt | 0001959173-26-007740 |
Track record
16 reports on GKOS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 Now $244.88 +0.91% settles Nov 23
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 Now $244.88 −0.34% settles Nov 20
- Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $237.60 to $224.41 Now $244.88 +3.06% ▼ −5.55% −2.85% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 Now $244.88 +0.99% ▼ −9.28% −4.55% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 Now $244.88 +32.70% ▲ +0.20% +1.56% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 Now $244.88 +31.21% ▲ +1.56% +2.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers